GV20 Oncotherapy Companies
We utilize high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. GV20's proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment
Investors
Connections from
Industry:
Healthcare Innovations
Employee Number:
5
Headquarters:
Shanghai, Shanghai, China